Free Trial

Baxter International (BAX) Competitors

Baxter International logo
$30.55 -0.91 (-2.88%)
As of 03:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BAX vs. BDX, EW, IDXX, RMD, DXCM, STE, PODD, HOLX, MASI, and GMED

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Masimo (MASI), and Globus Medical (GMED). These companies are all part of the "health care equipment" industry.

Baxter International vs.

Baxter International (NYSE:BAX) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, community ranking, media sentiment, earnings and analyst recommendations.

Baxter International presently has a consensus price target of $37.25, indicating a potential upside of 18.40%. Becton, Dickinson and Company has a consensus price target of $231.44, indicating a potential upside of 30.97%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, analysts clearly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
1 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.44
Becton, Dickinson and Company
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45

Baxter International has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500.

Baxter International pays an annual dividend of $0.68 per share and has a dividend yield of 2.2%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.4%. Baxter International pays out -61.8% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 79.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Becton, Dickinson and Company had 26 more articles in the media than Baxter International. MarketBeat recorded 33 mentions for Becton, Dickinson and Company and 7 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 1.45 beat Baxter International's score of 1.11 indicating that Becton, Dickinson and Company is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Becton, Dickinson and Company
27 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Baxter International received 131 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 65.57% of users gave Baxter International an outperform vote while only 62.09% of users gave Becton, Dickinson and Company an outperform vote.

CompanyUnderperformOutperform
Baxter InternationalOutperform Votes
737
65.57%
Underperform Votes
387
34.43%
Becton, Dickinson and CompanyOutperform Votes
606
62.09%
Underperform Votes
370
37.91%

90.2% of Baxter International shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 0.2% of Baxter International shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Becton, Dickinson and Company has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baxter International$10.77B1.50-$649M-$1.10-28.60
Becton, Dickinson and Company$20.87B2.43$1.71B$5.2433.73

Becton, Dickinson and Company has a net margin of 8.47% compared to Baxter International's net margin of -5.05%. Baxter International's return on equity of 16.67% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Baxter International-5.05% 16.67% 4.93%
Becton, Dickinson and Company 8.47%15.74%7.29%

Summary

Becton, Dickinson and Company beats Baxter International on 14 of the 20 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$16.14B$4.55B$5.43B$19.70B
Dividend Yield2.24%43.65%5.22%3.84%
P/E Ratio-24.5829.8726.8335.13
Price / Sales1.5071.05392.3534.12
Price / Cash6.4551.0838.2517.51
Price / Book1.886.346.874.78
Net Income-$649M$67.64M$3.22B$1.02B
7 Day Performance4.00%21.94%6.76%1.62%
1 Month Performance10.15%26.54%13.66%13.00%
1 Year Performance-8.68%22.75%18.27%5.59%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAX
Baxter International
4.7035 of 5 stars
$30.55
-2.9%
$37.25
+21.9%
-10.2%$15.68B$10.77B-23.8860,000Positive News
BDX
Becton, Dickinson and Company
4.9856 of 5 stars
$175.22
+4.8%
$231.44
+32.1%
-25.5%$50.22B$20.87B29.1177,000Positive News
High Trading Volume
EW
Edwards Lifesciences
3.9142 of 5 stars
$74.65
+1.3%
$79.45
+6.4%
-13.3%$43.88B$5.52B10.7117,300Positive News
IDXX
IDEXX Laboratories
3.4231 of 5 stars
$509.53
+3.6%
$524.75
+3.0%
-2.4%$40.98B$3.93B47.7510,800Positive News
Analyst Forecast
RMD
ResMed
4.1721 of 5 stars
$247.71
+1.1%
$258.83
+4.5%
+13.4%$36.32B$5.02B29.258,160News Coverage
Positive News
Analyst Revision
DXCM
DexCom
4.7571 of 5 stars
$85.05
+0.4%
$98.11
+15.4%
-33.2%$33.35B$4.15B59.487,600Positive News
STE
STERIS
4.5937 of 5 stars
$232.89
+2.9%
$258.75
+11.1%
+7.6%$22.88B$5.40B49.4516,000News Coverage
Earnings Report
Analyst Forecast
PODD
Insulet
4.459 of 5 stars
$316.67
+1.9%
$303.81
-4.1%
+77.8%$22.28B$2.07B54.692,600Positive News
HOLX
Hologic
4.9546 of 5 stars
$58.81
+3.6%
$78.58
+33.6%
-24.6%$13.11B$4.03B18.556,940
MASI
Masimo
4.6628 of 5 stars
$163.56
+4.5%
$191.60
+17.1%
+23.3%$8.87B$2.13B112.806,200Gap Up
GMED
Globus Medical
4.9016 of 5 stars
$58.98
+5.7%
$94.00
+59.4%
-7.0%$8.11B$2.51B78.642,600Buyback Announcement
High Trading Volume

Related Companies and Tools


This page (NYSE:BAX) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners